Meet Our Leadership Team
The Healthmap team is comprised of a unique blend of clinical and patient services specialists, and technology and data analytics experts. We are led by proven senior executives, with valuable guidance from our Board of Directors and Advisory Group, who are respected healthcare industry leaders.
As Chief Executive Officer, Joe is responsible for defining and realizing the strategic vision and product suite for Healthmap. In his role, Joe is constantly seeking data gaps in the healthcare delivery system. As Healthmap bridges those gaps, he has a passion for identifying opportunities to use that data to enrich the quality of care delivered and compress the cost of care, all while keeping the patient’s experience a top priority.
Joe has broad and deep experience in developing, underwriting, pricing, and managing value creating healthcare programs across multiple niches within healthcare. Joe was critical to driving organic growth, product development, acquisitions and business process improvement during his tenure as VP, Medical Economics at CareCentrix and Director, Health Services at WellCare Health Plans. Joe serves as a Director on the board of Heritage Property and Casualty Insurance (NYSE: HRTG). He earned his undergraduate degree in Mathematics from the University of Florida and his MBA from Georgetown University.
As Chief Operating Officer, Andrew is responsible for Healthmap’s population health and technology-enabled services, as well as company operations. Andrew brings a blend of valuable experience to Healthmap, having run growth businesses, built organizations and developed senior leaders throughout his career. Andrew also drives the company’s innovation efforts as SVP of Product, helping payors, providers and self-insured companies manage costs, while ensuring their populations receive the highest quality healthcare services.
Andrew brings years of diverse healthcare and technology industry experience with McKesson, Kaiser Permanente, Deloitte Consulting and Workday, having created innovative technology solutions for Health Plans, Hospital Systems, Providers and Medical Device Manufacturers, including a first-of-its-kind health information exchange. Andrew holds a M.S. degree from Columbia University and a B.S. degree from the Florida State University.
As Chief Growth Officer, Tom is responsible for the company’s growth expansion strategy, client relationships, and sales and marketing. In his role, Tom aligns the company’s extensive strengths and internal resources to bring the most effective low-cost, high-quality programs to patients living with kidney disease, supports providers in practicing best-in-class, lower-cost medicine and reduces spend and trend for payors.
Tom is a nationally recognized healthcare executive with more than 25 years of experience building and leading organizations that change traditional methods of high-cost, lower-quality healthcare services. An industry trailblazer, in 2006 Gaffney founded Sleep Management Solutions (SMS), the first Sleep Benefits Management (SBM) company in the country and effectively created the Sleep Benefits Management healthcare space. Before joining Healthmap Solutions, Gaffney was the Chief Customer Officer at CareCentrix, where he managed the company’s client portfolio and Account Management functions.
As Chief Clinical Quality Officer, Liz is responsible for the clinical validity of Healthmap’s products. She also guides the activities of Healthmap’s Scientific Advisory Board in the development of clinical algorithms, such as those applicable to the identification and treatment of chronically ill patients. Additionally, Liz applies her industry expertise in the areas of laboratory medicine, medical coding, translation of professional guidelines to practical implementation, quality assurance, and HIPAA compliance.
Liz brings a broad, unique perspective to the company with over 40 years of experience in health care, most of which was focused on laboratory medicine. She is board-certified in both genetics and clinical chemistry, is a Fellow of the American College of Medical Genetics and Genomics, and her experience spans commercial, academic, and non-profit settings. She has held a variety of roles in which she led the efforts of large, cross functional groups to drive organic growth through provision of high quality care. Her commercial experience includes over 11 years at Quest Diagnostics, and her academic experience includes faculty appointments at Harvard Medical School, Massachusetts General Hospital, Brandeis University, and the University of Pittsburgh, Graduate School of Public Health.
As Chief Actuary and Vice President of Medical Economics, Greg is responsible for developing effective cost-analysis reporting and utilization metrics in order to drive actionable business decisions. In this role, Greg uses his diverse healthcare background, including extensive knowledge of Medicare and Medicaid, and strategic focus to develop key performance metrics and cost savings opportunities for the organization as well as our clients.
Greg has over 20 years of experience as a healthcare actuary working in a variety of different settings with various responsibilities including product pricing, product development, risk adjustment, financial forecasting, government programs, and mergers and acquisitions. He has held various leadership roles at several large national healthcare payors, including Coventry Health Care, WellCare, Anthem BlueCross/Blue Shield and most recently was a Senior Consultant at an actuarial consulting firm specializing in Medicare bids and pricing models. Greg is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. He holds a BS degree from Purdue University.
As Chief Technology Officer, Ken is responsible for all of the company’s technology assets. His ability to lead, predict trends and react in real-time to the complex needs of our clients continually strengthens Healthmap Solution’s cutting-edge and highly scalable proprietary technology platform, Compass.
Ken has a diverse background including finance, healthcare, and benefit management organizations. He has created complex role-based user interfaces, middleware components and standalone applications while implementing strategies to balance transaction speed with reliability. Ken holds two degrees, a B.S. in Computer Sciences and a B.S. in Business Management, from Richard Stockton College of New Jersey and numerous technology-based certifications.
As Chief Information Security Officer (CISO), Kathleen is responsible for establishing and maintaining the enterprise vision, strategy, and program to ensure information assets and technologies are adequately protected. Kathleen is a cyber security expert responsible for the development, implementation, and administration of security matters. Kathleen uses her passion for information security to enable Healthmap to deliver services while appropriately protecting the data of our clients.
Kathleen is an internationally recognized executive and featured speaker on Governance, Risk, and Information Security specializing in healthcare. Kathleen’s background includes serving as CISO at Adventist Health, Healthplan Services, Tampa Airport, and WageWorks, firms that are not-for-profit, private equity, governmental, or publicly traded entities. Her memberships include Infragard, (ISC)2, and ISACA and she does volunteer work within the information security community. She has a B.S.B.A with a concentration in accounting from St Joseph’s College Maine and an MBA from Florida Metropolitan University. Her certifications include a CISSP from (ISC)2 and a CCSFP from HITRUST.
As Vice President of Human Resources, Kisha is responsible for providing strategic leadership and direction on all facets of HR management, as it relates to organizational development, performance management, recruiting and staffing, compensation and benefits, and employment law. Kisha applies her drive and experience to re-engineer processes and develop new procedures to maximize efficiency.
Having worked in the healthcare industry for the past 5 years, Kisha served as Head of Human Resources for Health Integrated and utilizes that knowledge to align the organization and accelerate Healthmap Solutions to the next level. She is an active member of SHRM, HR Tampa, and strives to stay current on all HR trends. Kisha holds a B.S. degree from the University of Florida.
As Vice President of Clinical Products, Amy is responsible for expanding and developing innovative programs that advance early detection of chronic kidney disease, defer its progression and deliver improved patient outcomes at lower costs. In this role, she integrates the kidney health, behavioral health and social determinant of health needs of patients with data and analytics, creating evidence-based personalized care plans that meet the needs of each patient.
Amy has over 20 years of experience leading clinical teams, healthcare executives and physician practices to drive positive change in care delivery systems and overall healthcare markets. She has developed and enhanced integrated networks of care, strategic alliances, physician and executive leadership relations, rural health and health education. Amy is the President of the National Kidney Foundation of Florida, past President of the Florida Renal Association and Board Member of Families with SCN2A Foundation, an organization created by parents of children diagnosed with rare forms of Epilepsy and Autism. She is a former DaVita executive in the areas of Business Development and Kidney Care. Amy earned her MSN, MBA and HCA from University of Phoenix, where she is currently a doctoral candidate.
Mr. Shulman serves as managing partner of Shulman Family Ventures, a private equity firm since 2008. He is the former chairman and chief executive officer of Magellan Health Services (NASDAQ:MGLN), where he spearheaded the company’s successful turnaround, restructuring out of bankruptcy, and diversification into the nation’s foremost specialty healthcare managed care company. He also led Prudential Healthcare through its major turnaround while serving as the company’s chairman, president and CEO, culminating in the company’s successful sale to Aetna. Steve was also the co-founder of Value Health, Inc. (a NYSE) managed care company specializing in behavioral health and prescription drug benefit management.
Steve currently serves as the Chairman of the Board of CareCentrix (privately held post-acute managed care company) and Quartet (privately held technology company focused on the integration of behavioral and physical medicine). He also currently serves as a director of VillageMD (privately held primary care medical management company), MedImpact (largest privately held prescription drug benefits management company-PBM), Healthmarkets (privately held healthcare distribution and specialty insurance company) and Facet Technologies (privately held OEM of lancets and lancing devices for diabetics).
Steve also served as Chairman of the Board of R1 (NASDAQ) healthcare revenue cycle management company, Health Management Associates (a NYSE listed national company that owned and operated 71 hospitals), where he successfully participated in a hostile takeover and engineered its sale to CHS for $7.6 B which closed in early 2014. Mr. Shulman previously founded Internet HealthCare Group, a venture fund focused on the intersection of early stage health care and technology companies. Prior to that Steve served in senior executive positions at Cigna and Kaiser.
Mr. Shulman’s qualifications as a director include his extensive experience in the healthcare industry, including serving as chief executive of several large healthcare sector organizations and as operating partner for a healthcare private equity firm, and his roles as a director of several privately held companies.
Mr. Reimer was CEO of CareCentrix, the leading home health benefits management company, from 2008 – 2013. During his tenure the company tripled in size to nearly $1B in annual revenue. He previously was an officer at Magellan from 2003 – 2008 where he served in three distinct roles. First, Eric was the P&L owner for the Behavioral Health plan West division, a $400M division serving 20+ health plans. Then he was promoted to Chief Growth Officer of Magellan responsible for M&A, strategy, and sales. During this period, Eric spearheaded acquisition of two companies: National Imaging Associates and ICORE specialty pharmacy, and the company sold $1B of new business. Finally, he became CEO of National Imaging Associates, and the company grew from $40M of revenue to $350M of revenue in eighteen months under his leadership. Eric was co-founder of Internet Healthcare Group where he wrote the initial business plans for Lumenos and Digital Insurance, and has held executive positions at CIGNA, Prudential Healthcare and the Boston Consulting Group. He recently served as a Board member for Digital Insurance, prior to their successful sale to Fidelity National Financial, and Triad Healthcare, prior to their successful sale to Medsolutions.
Eric received a BA in Economics from Washington University in St. Louis and an MBA from the Wharton School of Business with a concentration in Strategy and Health Care Management.
Ari Benacerraf is a Partner and member of the Investment Committee at Five Arrows Capital Partners, the U.S. middle-market private equity business of Rothschild Merchant Banking.
Prior to FACP, Ari co-founded Diamond Castle where he was a Partner since 2005. He played a leadership role as part of the Diamond Castle investment team and was a member of the firm’s Investment Committee. Ari focused primarily on the healthcare sector while at Diamond Castle. Representative investments in the healthcare sector included Managed Health Care Associates, Inc., Beacon Health Strategies, LLC, ValueOptions, Inc., Suture Express, Inc. and Healthmap Solutions, Inc.
From 2001 to 2004, Ari served as a Managing Director at DLJ Merchant Banking Partners, where he had been a Principal and a Vice President since 1995. Prior to DLJ, Ari served as a Vice President at Bankers Trust Company from 1992 to 1995. Previously he was an Associate at Banque Nationale de Paris. Ari currently serves on the board of Beacon Health Options, Suture Express, Multi-Color Corp. (Nasdaq: LABL) and Healthmap Solutions. Representative prior board appointments include: Managed Health Care Associates, Inc., NES Rental Holdings, Inc. and Catamount Energy Corporation.
Ari holds a BA in Chemistry from Franklin & Marshall College and an MBA from The Johnson School of Management of Cornell University.
Cherrill Farnsworth is an influential national expert on changing health care regulations and an entrepreneur who has founded seven successful companies over the course of her career.
In her role as an industry expert, Farnsworth is a regular speaker at business and health care symposia and is considered a national authority on changing health care regulations. Since 1984, Ms. Farnsworth has been a regular spokesperson for radiology management and reform before the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS). She has testified on the need to regulate quality in radiology at the House Ways & Means Committee and Congress. She is also a member of the National Quality Forum (NQF), which was formed by the U.S. Senate in response to the Institute of Medicine's report on medical mistakes.
Further, Farnsworth has served on the faculties of the Radiological Society of North America (RSNA) and the American Healthcare Radiology Administrators (AHRA), and on the editorial advisory boards of Imaging Economics and Advanced Imaging. She has regularly contributed articles to health care industry publications.
In addition, Farnsworth sits on several boards, including the American Association of PPOs (AAPAN), Vital Decisions, and HealthHelp, for which she serves as the board’s chairman.
Nationally recognized for her achievements, she has received the KPMG Peat Marwick High Tech Entrepreneur of the Year Award and the Ernst & Young Entrepreneur of the Year Award. The National Association of Specialty Health Organizations has named her “Most Influential in Specialty Health.” Under her progressive leadership, HealthHelp has been named multiple times to Inc. Magazine’s list of the 5000 fastest growing private companies in the United States and to the Houston Business Journal’s Fast 100, a list of the fastest growing companies in Houston.
Texas Executive Woman named her a Woman on the Move in 1986. In 2015, she was elected to the prestigious Committee of 200, a membership organization of the world’s most successful women entrepreneurs and corporate innovators. Also, Farnsworth is an active elected member of the Women Business Leaders of the U.S. Health Care Industry Foundation.
A graduate of Butler University, Ms. Farnsworth received her degree magna cum laude and has served on the school's board of trustees.
Oliver T. Moses serves as the Managing Partner of WindRose Health Investors and has spent the last 24 years as a healthcare industry investor and advisor. Prior to joining WindRose in early 2006, Mr. Moses worked in Merrill Lynch’s healthcare investment banking group where he was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies. Mr. Moses joined Merrill Lynch in 1994, and during his investment banking career, raised more than $6 billion for his clients and advised on M&A transactions with an aggregate value of $16 billion. Prior to investment banking, Mr. Moses was a healthcare-focused securities analyst in Merrill Lynch’s equity research department, where he was ranked as one of Wall Street’s “Up and Comers” by Institutional Investor’s All-America Research Team Survey.
Mr. Moses currently serves on the board of directors of basys, MDsave, myNEXUS, Shearwater Health, Trumpet Behavioral Health and Vital Decisions. Outside of his professional work, Mr. Moses serves on the board of the African Dream Academy Foundation and as a deacon of The Brick Presbyterian Church. He lives in New York City with his wife and two children.
Mr. Moses holds a Bachelor of Arts degree from Bowdoin College.
Mr. Pontius received his Bachelor of Science in Business Administration from The University of North Carolina at Chapel Hill. Prior to joining WindRose Health Investors in 2008, Mr. Pontius worked in the Healthcare Investment Banking Group of Oppenheimer & Co. (formerly CIBC World Markets), where he focused on strategic advisory, mergers and acquisitions and public and private company financings. Mr. Pontius currently serves on the board of directors of Kolmac, MDsave, Ovation Fertility, Shearwater Health, Traditions Behavioral Health, and TrustHCS.
Richard Popiel, M.D., MBA
Dr. Richard Popiel is a board-certified internal medicine physician and healthcare executive with over 26 years of experience leading patient-centric healthcare organizations. He is currently a Senior Advisor at McKinsey & Company.
Dr. Popiel recently retired from Cambia Health Solutions, a Portland, Oregon-based health solutions company where he served as the company’s Executive Vice President and Corporate Chief Medical Officer for over six years. At Cambia, he was responsible for clinical strategy to improve health plan members' outcomes and their experiences as healthcare consumers.
Prior to joining Cambia Dr. Popiel was President and Chief Operating Officer for Horizon Healthcare Innovations, a Horizon BlueCross BlueShield of New Jersey company, Vice President and Chief Medical Officer for Horizon BlueCross BlueShield of New Jersey, and Vice President and Senior Medical Director for The Permanente Company, a subsidiary of Kaiser Permanente.
Dr. Popiel serves on the Boards/Advisory Boards of Medecision, BioiQ, Tabula Rasa Healthcare, and Pager. He is also a member of the Board of The George Washington University Medical Associates, one of the largest medical groups in the District of Columbia.
Dr. Popiel received his doctorate of medicine degree from The George Washington University and a master’s degree from Northwestern University.
Prior to joining WindRose Health Investors in 2016, Mr. Stark was an analyst at UBS Investment Bank in the Leveraged Finance & Financial Sponsors Group, where he focused on leveraged buyouts, restructurings, recapitalizations, and capital markets across a range of industries. Mr. Stark received his Bachelor of Arts in Economics and French from Williams College.
Robert Cooper, MD, is attending physician in the department of endocrinology at Baystate Medical Center in Springfield, Massachusetts. Dr. Cooper received his medical degree from Albert Einstein College of Medicine, Bronx, New York, and completed residency training in internal medicine at Long Island Jewish Hospital, New Hyde Park, New York. He completed two combined years of fellowship training in endocrinology at Long Island Jewish Hospital and Winthrop–University Hospital, Mineola, New York.
Dr. Cooper specializes in all areas of endocrinology, including thyroid disorders; diabetes; adrenal, pituitary, and lipid disorders; disorders of metabolism; and osteoporosis. He is a former longstanding member of the Legislative and Regulatory Committee and also served on the Endocrine Board Review Committee of the AACE. He also has served on the Advisory Board for the Connecticut American Diabetes Association Annual Meeting since 2003, as an advisor to the Cardiometabolic Health Congress since 2005, and as Editor of MedStudy Internal Medicine Board Review since 2013.
Dr. Davis received his MD from the University of Kentucky in 1999, where he graduated with distinction and was named to Alpha Omega Alpha He completed residency in medicine and pediatrics in 2003 at the University of Cincinnati. Following his renal fellowship at the University of Cincinnati, Dr. Davis went into private practice for nephrology at The Kidney and Hypertension Center, where he served on the Board of Directors for three terms. Dr. Davis is currently an Assistant Professor of Medicine, Division of Nephrology, Department of Internal Medicine, for Washington University School of Medicine.
Dr. Forman is a practicing general cardiologist with interests in stress testing, echocardiography, lipidology and cardiovascular wellness. He attended medical school at The Ohio State University and completed his internal medicine residency at Emory University with subsequent cardiovascular disease training at The Medical College of Virginia/ Virginia Commonwealth University. Along with advisory and consultative roles, he comes to Healthmap with years of patient centered experience. A primary goal is using the knowledge and tools of a busy clinician applied to technology and data, thereby promoting wellness in an even larger population of at risk individuals.
Dr. Stuart Levine is currently the Chief Medical and Innovation Officer for Agilon Health. Prior to leading Agilon, Dr. Levine served as the Chief Innovation and Clinical Care Officer at Blue Shield at California where he was responsible for the ACO initiative state-wide, clinical optimization across all partner provider groups/ systems and business lines, strategic planning, medical management infrastructure development and government programs and clinical innovations for the enterprise.
Dr. Levine is an Assistant Professor of Internal Medicine and Psychiatry at the University of California, Los Angeles David Geffen School of Medicine since 1992 as well as resident expert on Population Health. Dr Levine is also an Assistant Clinical Professor of Internal Medicine at Stanford University School of Medicine.
Dr. Levine graduated from the University of Illinois College of Medicine at Chicago. He holds a Master’s degree in Healthcare Administration from George Washington University in Washington, D.C.
Dr. Thomas Nolin is a tenured Associate Professor in the Department of Pharmacy & Therapeutics, and in the Department of Medicine Renal-Electrolyte Division at the University of Pittsburgh. His primary research focuses on developing an understanding of the impact of kidney disease and renal replacement therapy (RRT) on nonrenal metabolism and transport pathways and corresponding effects on drug exposure and response. Dr. Nolin has a strong record of interdisciplinary and interinstitutional collaborations with regulatory, pharmaceutical industry, and academic scientists in the conduct of a broad range of clinical-translational studies in patients with kidney disease. He served as chair of the Kidney Health Initiative workgroup to assess pharmacokinetics during RRT and as co-chair of the Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup. Dr. Nolin has published over 120 manuscripts and book chapters and has presented more than 140 scientific abstracts and invited talks. He serves on the editorial board of the American Journal of Kidney Diseases, the Clinical Journal of the American Society of Nephrology, and as an Editor of the textbook Pharmacotherapy: A Pathophysiological Approach. Dr. Nolin is a Fellow of the American College of Clinical Pharmacy, the American College of Clinical Pharmacology, and of the American Society of Nephrology.
Dr. Nolin holds a B.S. in Pharmacy from the University of Connecticut, a M.S. in Pharmacy from the University of North Carolina, and Pharm.D. and Ph.D. degrees from the University of Pittsburgh.
Andrew D. Sherman
Mr. Sherman is currently the Chief Development Officer for Women's Care Enterprises, a leading multi-specialty provider of women's health services. Mr. Sherman also currently serves on the Board of KBL Merger Corp IV (NASDAQ:KBLM), a healthcare-focused special purpose acquisition corporation fund that went public in 2017 and Kolea Healthcare, a privately held home health company. Prior to Women's Care Enterprises, Mr. Sherman led corporate development for Unified Physician Management and previously was a Partner at DCH Partners, a healthcare-focused private equity firm focused on transaction development.
Mr. Sherman brings 25 years in investment banking, M&A and private equity to the advisory board having completed over 100 M&A and private equity transactions including over $35 billion in M&A transactions. Mr. Sherman holds a B.S. in Economics and Finance from The Wharton School of Business, a B.A. in International Relations from the University of Pennsylvania, and an M.B.A. with Distinction from The Harvard Graduate School of Business Administration.
As Clinical Program Architect, Dr. Warnes is responsible for leading the design of Healthmap’s current and future care management programs. Tom brings 25 years of valuable experience to Healthmap, having run large medical management divisions within the health plan, specialty benefit management, and health system space. A trained clinical psychologist, he brought his clinical expertise as a provider to the design and management of innovative clinical programs that improve quality and lower total health care costs. He has held senior executive positions within several large organizations, including WellCare, MunichRe, CHI hospital systems, and CareCentrix. Tom holds a BS, Chemistry degree from Michigan State University, and a PhD, Psychology degree from Southern California University.